ABSTRACT
Introduction
Lung cancer remains the commonest cause of cancer death in both man and women in the development world, and is one of the most important diseases in respiratory medicine 1 . Although cancer has often been regarded principally as a problem of the developed world, of the 10 million new cancer cases each year, 5.5 million of them are in developing countries. Every year, there are more than 6 million cancer deaths, accounting for 12% of all deaths in the world. Over the next 20 years, the number of cancer deaths annually will rise to some 10 million 2 .
Cancer arises principally as a consequence of exposure of individuals to carcinogenic agents in what they inhale or eat and drink, or through exposures at their work or elsewhere. Rather than inherited genetic characteristics, other factors play the major roles in the etiology of cancer. These include personal habits such as tobacco use and dietary patterns, occupational exposure to carcinogens, and biological factors such as viral hepatitis B infection and human papillomavirus infection 2 . Environmental air pollution and smoking habits are the main sources of inhalation exposure to carcinogenic agents such as polycyclic aromatic hydrocarbons (PAH). PAHs are currently recognized as one of major classes of environmental carcinogenic pollutants 3 . Benzo[a]pyrene (B[a]P) is a member of PAH family, and is often used as a model compound for PAH toxicity studies and has been shown to be a potent lung carcinogen in animal models of lung cancer. The selective carcinogenesis of the lung following exposure to B[a]P may be a consequence of many biochemical factors, including those that affect absorption, metabolism, and DNA repair 4 . B[a]P has been used as a prototype carcinogenic polycyclic aromatic hydrocarbons since its isolation from coal tar in the 1930's. It produce a wide range of toxicities, including carcinogenicity in experimental animals, and acute inhalation induces squamous cell papillomas and carcinomas in the trachea 5 . Although most cases of lung cancer could be prevented, the treatment of lung cancer is often disappointing. In the study of cancer, the efficacy of new treatment ideas in various cell lines can be investigated 6 . There are few animal models of human lung cancer, and a animal model of tumor permits the evaluation in vivo of new chemotherapic drugs in the treatment of bronchogenic lung cancer 7 . Animal models act as a bridge between in vitro studies in the laboratory and studies in humans. As such, they have had a major impact on the investigation of many medicals conditions. The mouse provides the best choice for an animal model because the mouse genome has been extensively studied and sequenced and close similarities exist with the human genome 8 . In parallel with studies in humans, these animal models can be used to evaluate methods of possible chemoprevention and early detection 9 . Spontaneous lung tumors in mice are similar in morphology, histopathology, and molecular characteristics to human adenocarcinomas. Mouse models for lung cancer can thus serve as a valuable tool not only for understanding the basic lung tumor biology bus also for the development and validation for new tumor intervention strategies 10 . The aim of this study is to elaborate an experimental model of pulmonary carcinogenesis in Wistar rats, and to establish the dose of benzopyrene and necessary time of application to the induction of cellular alterations compatible with pulmonary cancer in Wistar rats.
Methods
Male Rattus norvegicus albinus, Wistar lineage 08 to 12 weeks of age were obtained from UFMS central bioterio. Animals were housed four per cage on hardwood chip bedding and were given food and purified tap water ad libitum. Rats were randomized into treatment groups and were quarantined for 2 weeks prior to treatment, during which time they were acclimatized to 12-h light-dark cicles. B[a]P was suspended in alcohol 70% to obtain 10 and 20 mg/ml concentrations. Rats were anesthetized with a mixture of ketamine and xilazine, positioned in supine and a thoracocentesis with a 13X4,5 needle was realized in left lung. Rats (eight per group) were given a single intrapulmonary instillation of B[a]P at doses of 10 and 20 mg/kg using a 1-ml sterile syringe that was attached to the needle. The animals (two by two) were killed 08, 10, 12 and 14 weeks after the intrapulmonary instillation. A group of 08 rats (control) were also instilled with alcohol 70%. Until their sacrifice, all animals were maintained four per cage under controlled ambient conditions and with free access to food and water. Rats were killed by intraperithoneal infusion of lethal dose of sodium penthobarbital. The pulmonary sections had been colored by hematoxilin-eosin (HE) and submitted to the morphological analysis to describe the tissue alterations. All experiments respected the international rules for animal experimentation.
Results
The findings of the hystopathological analysis observed in the experimental groups at the sections colored by HE are described in the figures 01, 02, 03 and 04. Inflammatory alterations had been observed in all the animals of the analyzed groups, in three animals of the experimental group 10mg (08,10 and 14 weeks) and three of the experimental group 20mg (08, 12 and 14 weeks) had been observed lymphoid nodular hyperplasias (BALT, bronchial associated lymphoid tissue). Injury suggesting tumoral induction was observed at only one animal (experimental group 20mg, 12 weeks), which presented a pleomorphism suggesting an adenocarcinoma in situ in the tracheal epithelium. oxidant agent to the carcinogenic ones, induces greater release of pro-inflammatory mediators, contributing to the process of carcinogenesis activation 11 . In three animals of the experimental groups, the presence of BALT hyperplasia was observed. Although normally constitute inespecific injuries, Miranda et al., (2003) consider the hyperplasical injury as one of the alterations associated to the development of the lung cancer 15 . As other lymphomas, it is believed that BALT hyperplasia originates from a lymphoid hyperplasia for abnormal neoplasic selection, frequently associated to the antigenic interaction with environmental pollutants 16, 17 . All studied animals (including the control group) had presented some degree of inflammatory process. The inflammation has been associated to the development of diverse pulmonary illnesses, including the cancer. Especially in experiments using rats, the pulmonary inflammatory process is frequent and directly related to the incidence of lung cancer 3, 12 . In this study, a simple instillation of the dilution solution was carried through, probably causing the acute inflammatory process. Miranda et al., (2003) relate that the frequent genetic mutations secondary the tissular aggression occur continuously and are repaired by the cellular defense mechanism, that controls the growth, the latency and cellular apoptosis, emphasizing the need of the continuity of the inflammatory process at the carcinogenesis induction 15 . It was observed in this study that several degrees of inflammatory replies could be observed in all the analyzed moments (8, 10, 12 and 14 weeks after the instillation). Lu, Ouyang and Huang (2006), emphasize the importance of the continuous aggression at the cancer induction, affirming that in many cases the acute inflammation can contribute to the regression of the carcinogenesis 18 . To establish the ideal reply-dose to the development of the lung cancer, it becomes necessary the association to an activator agent of the pulmonary metabolic reply, which without it, the reaction to the B[a]P probably will be not enough to start the induction process of pulmonary neoplasias by mutagenesis.
Conclusion
The intra-pulmonary injection of Benzopyrene is an easy method of accomplishment, but the carcinogenic injury's observation occurred in only one animal (20mg/kg, 12 weeks). BALT lymphoid nodular hyperplasias (considered for some authors as possible pre-carcinogenic injury) occurred in six animals, suggesting that the intra-pulmonary injection can be an adequate model when used largest doses and observation periods. It had been observed in this study significant differences to the used doses at the cellular proliferation after the intra-pulmonary injection of B[a]P. Such differences had revealed to be time and dose-dependents. The main secondary alterations to the intra-pulmonary instillation of B[a]P in Wistar rats observed in this study had been: cellular proliferation, inflammatory alterations of several degrees and lymphoid nodular hyperplasias.
Discussion
In this study, it was opted to use rats at the development of the experimental model. According to Dawkins and Stockley (2001) , the rats represent the best option for animal models of illness, because its genoma has been extensively studied and its sequence shows similarities with the human genoma 8 . Meuwissen and Berns (2005) affirm that the spontaneous lung tumors in rats are similar in morphology, hystopathology and molecular characteristics of the human adenocarcinomas. Models of lung cancer in rats can serve, therefore, as a valuable tool not only to the understanding of the biological bases of these tumors, but also to the development and validation of new interventions and strategies to the cancer treatment, as well as the identification of markers for the early diagnosis 10 . It was opted in this study the injection of the diluted B[a]P by thoracocentesis, when Garçon et al. (2001) offers the tracheal instillation as a study option on the PAH effects at the pulmonary tissue 11 . Similar methodology to this study was used by Harrigan et al. (2004) . The authors tell that, in despite of the injection with thoracocentesis be apparently the most efficient method of cancer induction, the low metabolic activation found in the pulmonary tissue can disable the action of the B[a]P while carcinogenic 4 . Gerde et al. (2001) emphasize the paper of the tissular metabolism in the elimination of the PAH, telling in its study that only 23% of the instilled dose in the tracheal epithelium is effectively absorbed. Studies using repeated intra-tracheal administrations of PAH had been incapable to get the reply-dose necessary to the induction of lung cancer with accuracy 12 . The induction method and the dose used are related as a greatly influent component at the pulmonary carcinogenesis 10 . The analysis of the available literature, references had not been found on the accurate reply-dose of B[a]P enough to the induction of pulmonary carcinogenesis, however it observes that at the studies which outcomes related the instillation of B[a]P to tissular alterations, molecular or genetic in the lungs, the doses had varied between 10mg/kg and 50mg/kg 4, 11, 12 . It was used coloration by HE for the hystopathological analysis. According to Franklin (2000) the analysis of the microscopical findings of the tumoral sections colored by HE are still the most commonly method used to the classification of the lung cancer 13 . In only one of the studied animals, the neoplasia alterations had been found (pleomorphism suggesting adenocarcinoma in situ), observed specifically in the tracheal epithelium. Rubin (2001) relates that almost the totality of the PAH are completely carcinogenic, not being necessary other interventions at the experimental cancer induction, however, emphasizes several times in his study that such property is conditioned to the presence of epithelial tissue 14 . Non-observation of the alterations compatible with lung cancer (the exception of an animal of the experimental group 20mg/kg), can be explained by the absence of metabolic activation. Garçon et al. (2001) suggest that the exposition to an associated
